ETFs
T
TARS
Tarsus Pharmaceuticals, Inc.
71.08
+1.58+2.27%Opening13:02 10/20 EDT
OPEN/PREV CLOSE69.54/69.50
TODAY RANGE67.93-72.46
VOL295.61K
MARKET CAP3.50B
52 WEEK RANGE53.89-91.53
AVG VOL (3M)849.64K
% TURNOVER0.60%
TURNOVER--
P/E (TTM)-65.7554
% RANGE6.52%
EPS(TTM)-1.0809
P/E(FORWARD)-14.8460
P/B8.87
BVPS8.01
DIVIDEND--
P/S6.70
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.35B
SHARES OUTSTANDING49.30M
NEXT EARNINGS11/02-11/06
FREE FLOAT47.16M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
Tarsus Pharmaceuticals (TARS) Could Be 32% Undervalued After New Shelf Registrations
Simply Wall St·10/09 17:40
Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Profit Outlook
Seeking Alpha·10/06 13:09
Oppenheimer's fall 2026 SMID-cap ideas include four Strong Buy stocks
Seeking Alpha·10/06 12:55
Tarsus Pharmaceuticals: XDEMVY Now Pays The Bills, And The Retina Deals Work Like Options
Dow Jones·09/24 12:14
Tarsus Pharmaceuticals Price Target Announced at $116.00/Share by Goldman Sachs
TipRanks·09/24 08:50
Tarsus Pharmaceuticals resumed with a Buy at Goldman Sachs
TipRanks·09/24 08:35
Tarsus Pharmaceuticals (TARS) Receives a Buy from Goldman Sachs
Dow Jones·09/16 13:05
Tarsus Pharmaceuticals Price Target Announced at $110.00/Share by Barclays
Same Industry
Name/Symbol
Change%
Price